Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice.
Fung
J J
JJ
Pittsburgh Transplant Institute, University of Pittsburgh Medical Center, PA, USA.
Eghtesad
B
B
Todo
S
S
Rakela
J
J
Magnone
M
M
Starzl
T E
TE
D000998:Antiviral Agents / Q000627:therapeutic use; D006509:Hepatitis B / Q000209:etiology* / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000627:therapeutic use; D006515:Hepatitis B virus; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D012008:Recurrence; D014183:Transplantation, Heterologous
D000998:Antiviral Agents; D006510:Hepatitis B Antibodies